Telemedicine and
            <scp>COVID</scp>
            ‐19 pandemic: The perfect storm to mark a change in diabetes care. Results from a world‐wide cross‐sectional web‐based survey

Giani, Elisa; Dovč, Klemen; Santos, Tiago Jeronimo Dos; Chobot, Agata; Braune, Katarina; Cardona-Hernández, Roque; Beaufort, Carine de; Scaramuzza, Andrea

doi:10.1111/pedi.13272

Cited by 34 publications

(41 citation statements)

References 18 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Previous studies have shown the fundamental role and the effectiveness of telemedicine use in improving patient glycemic control during Covid-19 pandemic ( 23 – 28 ). Several studies that investigate the satisfaction of the pediatric population in the use of telemedicine have recently been published ( 13 – 17 ), but only a few have evaluated satisfaction in patients with Type 1 diabetes.…”

Section: Discussionmentioning

confidence: 99%

Patient Satisfaction of Telemedicine in Pediatric and Young Adult Type 1 Diabetes Patients During Covid-19 Pandemic

Bassi

Strati

Parodi

et al. 2022

Front. Public Health

View full text Add to dashboard Cite

The aim of this study was to evaluate the satisfaction of the use of telemedicine and telenursing in children and young adults with Type 1 Diabetes and their families followed in the Regional Pediatric Diabetes Center of Giannina Gaslini Institute (Liguria, Italy). An anonymous survey form was administered to 290 patients (138 filled out by caregivers and 152 by patients). The questionnaire consisted of two parts: the first one included a series of questions related to the patient's personal and medical data; the second one was directed toward the satisfaction in the use of telemedicine and telenursing during Covid-19 pandemic. The data collected showed that 92.4% of the population was overall very satisfied with the quality of the service provided. Satisfaction was much higher especially in those who live outside of the province of Genoa (p = 0.017) and in those on insulin pump treatment (p = 0.037). Telemedicine and telenursing have an essential role in diabetology and are highly appreciated in our Center, where most patients prefer to continue regular follow-up via video-call as well as in person. Telenursing was also proved to be an effective and appreciated tool for educating and supporting patients using insulin pumps and glucose sensors.

show abstract

Section: Discussionmentioning

confidence: 99%

Patient Satisfaction of Telemedicine in Pediatric and Young Adult Type 1 Diabetes Patients During Covid-19 Pandemic

Bassi

Strati

Parodi

et al. 2022

Front. Public Health

View full text Add to dashboard Cite

show abstract

“…A recent analysis of web-based surveys shows a rapid and distinct increase in telemedicine usage for routine diabetes care in different countries. 41 We expect a wider usage of CGM-derived metrics to assess metabolic control in the future, now accelerated by telemedicine care during the COVID pandemic.…”

Section: Discussionmentioning

confidence: 99%

Metabolic control during the SARS‐CoV ‐2 lockdown in a large German cohort of pediatric patients with type 1 diabetes: Results from the DPV initiative

et al. 2022

View full text Add to dashboard Cite

Objective To assess if metabolic control worsened during the SARS‐CoV2 lockdown in spring 2020 in youth with type 1 diabetes (T1D) in Germany. Methods Data from 19,729 pediatric T1D patients from the diabetes prospective follow‐up (DPV) registry were available. Data sets from four time‐periods between January 1 and June 30, 2020, were compared with data from the whole year 2019 in the same patient; differences were adjusted for seasonality, increasing age, and longer diabetes duration. HbA1c values from laboratory measurements and estimates derived from continuous glucose monitoring (CGM) were aggregated into a combined glucose indicator (CGI), expressed in analogy to HbA1c. Results Based on regression models adjusted for differences of sex, age, diabetes duration, and migratory background between the four time‐periods, CGI values in 2020 were slightly higher than in 2019, for example, by 0.044% (0.042–0.046) (median [95% CI]) in the second lockdown month, time‐period 3. Insulin dose and BMI‐SDS were also marginally higher. In 2020, there were fewer hospitalizations (e.g., incidence risk ratio in time‐period 3 compared with 2019: 0.52 [95% CI: 0.46–0.58]). In a subgroup of patients reporting CGM data in both years, metrics in 2020 improved: time in target increased, and mean sensor glucose fell, for example, by 2.8% (2.7–2.9), and by 4.4 mg/dl (4.3–4.6) in time‐period 3. Conclusion Before, during, and after the lockdown in spring 2020, metabolic control in youth with T1D in Germany did not differ significantly from the preceding year. Further effects of the ongoing pandemic on pediatric T1D patients need to be evaluated.

show abstract

“…Moreover, several practical and ethical issues still represent a limit to telemedicine use, that have to be resolved before a more diffuse application of this modality of health care: telemedicine technologies require adequate patients and healthcare professional training, accurate data management, and privacy, security protection, reimbursement policy application, and governance guidelines [ 78 – 81 ]. As clearly specified by March et al, in their Editorial, a correct approach to diabetes care through telemedicine, should be a multidisciplinary approach [ 82 ].…”

Section: Limitations To the Use Of Telemedicine And Future Perspectivesmentioning

confidence: 99%

Telemedicine for the Clinical Management of Diabetes; Implications and Considerations After COVID-19 Experience

Kreutzenberg

2022

High Blood Press Cardiovasc Prev

View full text Add to dashboard Cite

Telemedicine is a clinical approach that was seldom used in the day-to-day practice, if not only in certain settings, before the COVID-19 pandemic. As stated by the WHO, telemedicine is: the delivery of health care services, where distance is a critical factor, by all health care professionals using information and communication technologies (ICT) for the exchange of valid information for diagnosis, treatment and prevention of disease and injuries, …. Telemedicine has actually represented the most useful and employed tool to maintain contacts between patients and physicians during the period of physical distance imposed by the pandemic, especially during the lockdown. Diabetes in particular, a chronic disease that often needs frequent confronting between patient and health professionals has taken advantage of the telehealth approach. Nowadays, technological tools are more and more widely used for the management of diabetes. In this review results obtained by telemendicine application in type 1 and type 2 diabetic individuals during COVID-19 are revised, and future perspectives for telemedicine use to manage diabetes are discussed.

show abstract

Telemedicine and COVID ‐19 pandemic: The perfect storm to mark a change in diabetes care. Results from a world‐wide cross‐sectional web‐based survey

Cited by 34 publications

References 18 publications

Patient Satisfaction of Telemedicine in Pediatric and Young Adult Type 1 Diabetes Patients During Covid-19 Pandemic

Patient Satisfaction of Telemedicine in Pediatric and Young Adult Type 1 Diabetes Patients During Covid-19 Pandemic

Metabolic control during the SARS‐CoV ‐2 lockdown in a large German cohort of pediatric patients with type 1 diabetes: Results from the DPV initiative

Telemedicine for the Clinical Management of Diabetes; Implications and Considerations After COVID-19 Experience

Contact Info

Product

Resources

About